Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Corneal Neovascularization Vaccines
Research on corneal neovascularization vaccines reported by scientists at Keio University, Department of Ophthalmology
June 4th, 2008
Current study results from the report, 'Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2,' have been published. In this recent report published in the journal Investigative Ophthalmology & Visual Science, researchers in Tokyo, Japan conducted a study "To investigate whether the induction of cytotoxic T lymphocytes (CTLs) targeting VEGF receptor 2 inhibits corneal neovascularization caused by alkali injury. H-2Db-restricted peptide corresponding to amino acids 400 to 408 of VEGF receptor 2 (VEGFR2(400-408)) was used as an epitope peptide." "Dendritic cells (DCs) were harvested from bone marrow...
Source: Vaccine Weekly (2008-06-04)
|
